source
- Gilead places partial clinical hold on two KITE-753 CAR-T trials in diffuse large B-cell lymphomaGilead announced on its third-quarter earnings call that it has placed a partial clinical hold on two CAR-T trials for KITE-753 targeting diffuse large B-cell lymphoma (DLBCL). The hold affects th…
- Federal rule forces PBMs to disclose fees and rebates to employersThe Trump administration finalized a regulation that will require pharmacy benefit managers (PBMs) to reveal the various fees and compensation they receive from drugmakers, consultants and other pa…